A carregar...

Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells

Chronic lymphocytic leukemia (CLL) is an incurable progressive disease for which new therapies are required. Therapy with monoclonal antibodies (mAbs) has improved the outcome of patients with CLL, making further investigation of novel antibodies directed against alternative and specific targets on...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hertlein, Erin, Triantafillou, Georgia, Sass, Ellen J., Hessler, Joshua D., Zhang, Xiaoli, Jarjoura, David, Lucas, David M., Muthusamy, Natarajan, Goldenberg, David M., Lee, Robert J., Byrd, John C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2953888/
https://ncbi.nlm.nih.gov/pubmed/20574049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-11-253203
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!